What is he best known for?
The fields of study he is best known for:
Gerald Münch mostly deals with Glycation, Oxidative stress, Biochemistry, Alzheimer's disease and Neuroprotection.
The various areas that he examines in his Glycation study include Inflammation, Cell damage and Peptide.
His work deals with themes such as Cancer research, Neurodegeneration, Disease, Pathology and Nitrotyrosine, which intersect with Oxidative stress.
His Neurodegeneration study combines topics in areas such as Neurotoxicity, Programmed cell death, Neuroscience and Intracellular.
While the research belongs to areas of Alzheimer's disease, Gerald Münch spends his time largely on the problem of Immunology, intersecting his research to questions surrounding Senile plaques.
Gerald Münch has included themes like Lipid peroxidation, Surgery and Ageing in his Neuroprotection study.
His most cited work include:
- Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease. (340 citations)
- Brain Atrophy in Type 2 Diabetes Regional distribution and influence on cognition (284 citations)
- Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. (261 citations)
What are the main themes of his work throughout his whole career to date?
Gerald Münch spends much of his time researching Biochemistry, Glycation, Oxidative stress, Internal medicine and Endocrinology.
His research on Biochemistry often connects related areas such as Molecular biology.
Gerald Münch interconnects Alzheimer's disease, Nitric oxide and Intracellular in the investigation of issues within Glycation.
His Oxidative stress research incorporates elements of Antioxidant, Inflammation, Neurodegeneration, Neuroprotection and Pathology.
In his research on the topic of Inflammation, Neuroinflammation is strongly related with Pharmacology.
His study in Neurodegeneration is interdisciplinary in nature, drawing from both Neuroscience and Programmed cell death.
He most often published in these fields:
- Biochemistry (33.97%)
- Glycation (29.19%)
- Oxidative stress (23.44%)
What were the highlights of his more recent work (between 2013-2021)?
- Neuroinflammation (8.13%)
- Anti-inflammatory (7.18%)
- Pharmacology (15.79%)
In recent papers he was focusing on the following fields of study:
Neuroinflammation, Anti-inflammatory, Pharmacology, Microglia and Inflammation are his primary areas of study.
His Neuroinflammation study integrates concerns from other disciplines, such as Alzheimer's disease and Neuroscience.
His studies deal with areas such as No production, Nitric oxide, Downregulation and upregulation, Biochemistry and Traditional medicine as well as Anti-inflammatory.
His Biochemistry research is multidisciplinary, incorporating elements of Choline acetyltransferase and Molecular biology.
His research integrates issues of Macrophage, Senile plaques and Pathology in his study of Inflammation.
His work on RAGE is typically connected to In situ hybridization as part of general Glycation study, connecting several disciplines of science.
Between 2013 and 2021, his most popular works were:
- Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease. (94 citations)
- Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease (85 citations)
- Curcumin and Apigenin - novel and promising therapeutics against chronic neuroinflammation in Alzheimer's disease (82 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Pharmacology, Neuroinflammation, Microglia, Curcumin and Neuroprotection.
His Neuroinflammation study combines topics from a wide range of disciplines, such as Alzheimer's disease and Neurodegeneration.
His work on Amyloid precursor protein as part of his general Alzheimer's disease study is frequently connected to Epigallocatechin gallate, thereby bridging the divide between different branches of science.
The various areas that Gerald Münch examines in his Neurodegeneration study include Diabetes mellitus, Glycation and Cell cycle, Cyclin D1.
His biological study deals with issues like Cytokine, which deal with fields such as Inflammation.
His Neuroprotection study combines topics in areas such as Apigenin and Resveratrol.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
